The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Study sponsor: COMPASS Pathways
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-02-12Actual
Enrollment · participants22Actual
Source updated2025-06-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.